Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies

BACKGROUND: Although migraine is less common in older people, preventive treatment of migraine in these individuals may be more challenging due to the presence of multiple comorbidities and polypharmacy. Additionally, evidence for migraine treatment efficacy, safety, and tolerability is limited in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nahas, Stephanie J., Naegel, Steffen, Cohen, Joshua M., Ning, Xiaoping, Janka, Lindsay, Campos, Verena Ramirez, Krasenbaum, Lynda J., Holle-Lee, Dagny, Kudrow, David, Lampl, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903616/
https://www.ncbi.nlm.nih.gov/pubmed/34819017
http://dx.doi.org/10.1186/s10194-021-01351-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903616/
https://www.ncbi.nlm.nih.gov/pubmed/34819017
http://dx.doi.org/10.1186/s10194-021-01351-2

Ejemplares similares